Literature DB >> 3025608

Structure of the protein encoded by the chicken proto-oncogene c-myb.

S Gerondakis, J M Bishop.   

Abstract

The retroviral oncogene v-myb arose by transduction of the chicken proto-oncogene c-myb. We isolated and sequenced cDNA that represents the entire coding domain of chicken c-myb. By transcribing the cDNA into mRNA in vitro and then translating the RNA, we were able to document the integrity of the cDNA and to identify the codon responsible for initiation of translation from c-myb. Two different alleles of v-myb are extant, one in the genome of avian myeloblastosis virus (AMV) and the other in the genome of erythroblastosis virus 26 (E26V). The proteins encoded by the AMV and E26V alleles of v-myb differ from the product of c-myb in three ways: at their amino termini, they lack 71 and 80 amino acids respectively; at their carboxy termini, they are deficient in 199 and 278 residues; and 11 substitutions of amino acids are scattered throughout the product of AMV allele, whereas the product of the E26V allele contains only a single substitution. The structural origins of tumorigenicity by v-myb and the biological functions of c-myb remain enigmatic. The findings and molecular clones described here should now permit a systematic exploration of these enigmas.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025608      PMCID: PMC367128          DOI: 10.1128/mcb.6.11.3677-3684.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  Transcripts from the cellular homologs of retroviral oncogenes: distribution among chicken tissues.

Authors:  T J Gonda; D K Sheiness; J M Bishop
Journal:  Mol Cell Biol       Date:  1982-06       Impact factor: 4.272

Review 2.  Leukemic transformation with avian myeloblastosis virus: present status.

Authors:  C Moscovici
Journal:  Curr Top Microbiol Immunol       Date:  1975       Impact factor: 4.291

3.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

4.  Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing.

Authors:  F Sanger; A R Coulson; B G Barrell; A J Smith; B A Roe
Journal:  J Mol Biol       Date:  1980-10-25       Impact factor: 5.469

5.  Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene.

Authors:  K H Klempnauer; T J Gonda; J M Bishop
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

6.  Two mRNAs can be produced from a single immunoglobulin mu gene by alternative RNA processing pathways.

Authors:  P Early; J Rogers; M Davis; K Calame; M Bond; R Wall; L Hood
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

Review 7.  Mechanism of mRNA recognition by eukaryotic ribosomes during initiation of protein synthesis.

Authors:  M Kozak
Journal:  Curr Top Microbiol Immunol       Date:  1981       Impact factor: 4.291

8.  Two modes of c-myb activation in virus-induced mouse myeloid tumors.

Authors:  G L Shen-Ong; H C Morse; M Potter; J F Mushinski
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

9.  A system for shotgun DNA sequencing.

Authors:  J Messing; R Crea; P H Seeburg
Journal:  Nucleic Acids Res       Date:  1981-01-24       Impact factor: 16.971

10.  The product of the retroviral transforming gene v-myb is a truncated version of the protein encoded by the cellular oncogene c-myb.

Authors:  K H Klempnauer; G Ramsay; J M Bishop; M G Moscovici; C Moscovici; J P McGrath; A D Levinson
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

View more
  39 in total

1.  Characterization of the v-myb DNA binding domain.

Authors:  T Oehler; H Arnold; H Biedenkapp; K H Klempnauer
Journal:  Nucleic Acids Res       Date:  1990-04-11       Impact factor: 16.971

2.  Definition of functional domains in P135gag-myb-ets and p48v-myb proteins required to maintain the response of neuroretina cells to basic fibroblast growth factor.

Authors:  C Garrido; D Leprince; J S Lipsick; D Stehelin; D Gospodarowicz; S Saule
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

3.  Protein truncation is required for the activation of the c-myb proto-oncogene.

Authors:  F A Grässer; T Graf; J S Lipsick
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

4.  Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M.

Authors:  M Oelgeschläger; R Janknecht; J Krieg; S Schreek; B Lüscher
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

5.  Acute myeloid leukemia induction by amphotropic murine retrovirus (4070A): clonal integrations involve c-myb in some but not all leukemias.

Authors:  L Wolff; R Koller; W Davidson
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

6.  A temperature-sensitive phenotype of avian myeloblastosis virus: determinants that influence the production of viral mRNAs.

Authors:  S Schirm; G Moscovici; J M Bishop
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

7.  Hematopoietic lineage-specific heterogeneity in the 5'-terminal region of the chicken proto-myb transcript.

Authors:  W K Kim; M A Baluda
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

8.  DNA-binding activity associated with the v-myb oncogene product is not sufficient for transformation.

Authors:  C E Ibanez; A Garcia; U Stober-Grässer; J S Lipsick
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

9.  v-myb blocks granulocyte colony-stimulating factor-induced myeloid cell differentiation but not proliferation.

Authors:  G Patel; B Kreider; G Rovera; E P Reddy
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

10.  Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene.

Authors:  H Sakura; C Kanei-Ishii; T Nagase; H Nakagoshi; T J Gonda; S Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.